The HCPLive endocrinology page is a comprehensive resource for clinical news and insights on endocrine system conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for diabetes, hormonal disease, and more.
November 16th 2024
Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with diabetes in the BPROAD trial.
HCPLive Endocrinology's flagship diabetes podcast, hosted by Diana Isaacs, PharmD, and Natalie Bellini, DNP
Aleglitazar Does Not Improve Post-ACS Outcomes in Patients with Type 2 Diabetes
March 31st 2014The AleCardio trial was halted early due to safety concerns and lack of efficacy. Investigators reported patients with diabetes and acute coronary syndrome experienced elevated risk of heart failure, gastrointestinal hemorrhage, and renal dysfunction with no mitigating cardiovascular benefit.
Hyponatremia Associated with Poorer Overall Survival in Renal Cell Cancer Patients
Hyponatremia is associated with poorer overall survival, time to treatment failure, and disease control in patients with metastatic renal cell cancer, according to a study published in European Urology.
Growing up with Diabetes: Transitioning from Pediatric to Adult Care
March 27th 2014As they age, children who are diagnosed with diabetes shift from care supervised by parents or caregivers to self-care. Ultimately, they must leave their pediatric care providers and find internists and other caregivers whose practices target adults.
Coming Soon: The Artificial Pancreas
March 25th 2014This closed-loop insulin delivery system monitors blood glucose continuously and utilizes an algorithm that senses glucose levels and autonomously delivers the required insulin dose. In contrast, conventional insulin pumps contain computer chips that allow patients to program insulin doses for scheduled delivery throughout the day.
Let the Buyer Beware of Direct-to-consumer Advertising
March 10th 2014Whether direct-to-consumer advertising is a good or bad thing remains a matter for debate, but what is not up for discussion is the need for due diligence on the part of physicians in managing patients who are motivated by those ads to seek medical attention.